Hussman Strategic Advisors Inc. Trims Holdings in Pediatrix Medical Group, Inc. $MD

Hussman Strategic Advisors Inc. reduced its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 20.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 168,000 shares of the company’s stock after selling 42,000 shares during the period. Hussman Strategic Advisors Inc. owned approximately 0.19% of Pediatrix Medical Group worth $2,814,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Royal Bank of Canada boosted its stake in shares of Pediatrix Medical Group by 23.8% during the first quarter. Royal Bank of Canada now owns 22,097 shares of the company’s stock worth $320,000 after buying an additional 4,247 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Pediatrix Medical Group by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 51,253 shares of the company’s stock worth $743,000 after acquiring an additional 2,251 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Pediatrix Medical Group by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company’s stock worth $3,891,000 after acquiring an additional 12,171 shares during the period. State of Alaska Department of Revenue grew its stake in shares of Pediatrix Medical Group by 7.0% in the 2nd quarter. State of Alaska Department of Revenue now owns 50,096 shares of the company’s stock valued at $717,000 after purchasing an additional 3,262 shares during the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Pediatrix Medical Group by 8.7% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company’s stock valued at $171,000 after purchasing an additional 950 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Down 3.7%

Shares of NYSE MD opened at $20.55 on Wednesday. The stock has a market capitalization of $1.76 billion, a price-to-earnings ratio of 10.81 and a beta of 0.73. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $24.99. The firm has a 50-day moving average price of $22.31 and a 200 day moving average price of $18.60. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.65.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.21. The company had revenue of $492.88 million during the quarter, compared to analysts’ expectations of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The firm’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same period last year, the company posted $0.44 earnings per share. Equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael A. Rucker sold 10,478 shares of Pediatrix Medical Group stock in a transaction on Monday, November 17th. The stock was sold at an average price of $23.00, for a total transaction of $240,994.00. Following the completion of the transaction, the director owned 59,101 shares of the company’s stock, valued at $1,359,323. The trade was a 15.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Laura A. Linynsky sold 10,000 shares of the stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $21.65, for a total transaction of $216,500.00. Following the completion of the sale, the director directly owned 32,232 shares in the company, valued at approximately $697,822.80. The trade was a 23.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 43,478 shares of company stock worth $972,924. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. Truist Financial boosted their price target on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a “hold” rating in a research note on Monday, November 10th. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 4th. Finally, UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $21.00.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.